Cornerstone Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Cornerstone Financial Management's VRTX Position: Q2 2026 in Review
Cornerstone Financial Management increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q2 2026, buying an estimated $11.1K and bringing the position to 209 shares worth $104K. The position accounts for 0.08% of the portfolio, ranked #120.
Cornerstone Financial Management first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,753 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Cornerstone Financial Management held 209 shares of Vertex Pharmaceuticals worth $104K as of Q2 2026.
- Cornerstone Financial Management bought 25 Vertex Pharmaceuticals shares in Q2 2026, an estimated $11.1K.
- Vertex Pharmaceuticals made up 0.08% of Cornerstone Financial Management's portfolio in Q2 2026, its #120 holding.
- Cornerstone Financial Management first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,753 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.